New drug molecule for treatment of atrial fibrillation
Disease control, safe medications critical to pregnancies for women with rheumatic disease
18 July 2022Prostaglandin E1 enhances safety of extracorporeal membrane oxygenation procedure
18 July 2022New drug molecule for treatment of atrial fibrillation
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The 8-member research team took eight years to achieve this technological breakthrough that could benefit millions of AF patients worldwide.
